Larimar Therapeutics LRMR Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS estimate-$0.47
Next report
Aug 13, 2026 (in a month)EPS estimate-$0.39
Versus estimates
Revenue
Diluted EPS
Ask the moment Larimar Therapeutics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Larimar Therapeutics report Q2 2025 earnings?
- Larimar Therapeutics (LRMR) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were Larimar Therapeutics's Q2 2025 revenue and EPS?
- Larimar Therapeutics reported diluted EPS of $-0.41 for Q2 2025.
- Did Larimar Therapeutics beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-0.47 by $0.06.
- How did Larimar Therapeutics's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS declined 20.6% from $-0.34.
- Where can I find Larimar Therapeutics's Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-108797) directly on SEC EDGAR. The filing index links above go to sec.gov.